How would you know what the results are of the current trial with Merck are? Do you think they would say gee the results are excellent and then months later buy the company? Or would you impose a quiet period for months, drive the price down and accumulating shares during the approval process?
Truth will out. So far all of this is true -- Merck has shown no interest.
Your DD is second to none :-d
No interest huh?
That's why Merck got UCLA to throw out Bristol Meyers Squibb from the SPORE 1 project in 2019 and replace Opdivo (nivolumab) with Keytruda (pembrolizumab), which is now the combo trial. A combo trial where Merck is sponsoring Keytruda FOR FREE, which big pharma usually DON'T DO.
I love your due diligence. It gives me some of the most humoristic moments every week.
Oh ... that is the cue for you claiming, that ATL-DC is not DCvax-L. That Linda Liau has distanced herself from NWBO (which is why she will talk about DCVax-L 3 times the next month) and she is making her "own version".